AI Helps ALS Patients Communicate Uniquelyby Lilu Anderson 15.08.2024Brain implants and AI voice technology enable ALS patients to communicate effectively.
Preparing for New U.S. Biotech Legislationby Lilu Anderson 15.08.2024Companies must adapt as U.S. advances biotech bill restricting Chinese suppliers.
Exploring Private Finance for £9bn Thames Crossingby Mark Eisenberg 15.08.2024Rachel Reeves considers private funds for Lower Thames Crossing, aiming to fulfill a £22bn gap in UK infrastructure finance.
Beam Therapeutics: Genetic Medicine Pioneerby Lilu Anderson 15.08.2024Beam Therapeutics leads with CRISPR in treating genetic diseases, opening new market avenues.
Universal IRA Transforms Retirement Investingby Mark Eisenberg 14.08.2024Equity Trust's Universal IRA offers flexibility with traditional and alternative asset investments.
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapyby Lilu Anderson 14.08.2024Kezar halts tumor drug trials, pivots to autoimmune hepatitis focus with promising zetomipzomib.
Mercury Systems Shares Surge on Q4 Earnings Beatby Mark Eisenberg 14.08.2024Mercury Systems shares rose 10% after Q4 earnings beat expectations with $248.6M in revenue and a $0.23 EPS.
UBS Surpasses Profit Forecasts Amid Strong Investment Gainsby Mark Eisenberg 14.08.2024UBS posts outstanding profits, driven by investment banking and Credit Suisse integration, elevating share value by 3.6%.
ASIC Sues ASX for Misleading Statements on CHESSby Mark Eisenberg 14.08.2024Australian regulator sues ASX for misleading investors about CHESS project readiness, affecting market confidence.
BlackRock’s Ethereum ETF Nears $1B Milestoneby John Darbie 14.08.2024BlackRock's ETH ETF is set to hit $1B amid bullish trends, boosting Ethereum's market outlook.